Life,
Journal Year:
2023,
Volume and Issue:
13(8), P. 1640 - 1640
Published: July 28, 2023
A
urine
test
permits
the
measure
of
several
urinary
markers.
This
is
a
non-invasive
method
for
early
monitoring
potential
kidney
damage.
In
COVID-19
patients,
alterations
markers
were
observed.
review
aims
to
evaluate
utility
urinalysis
in
predicting
severity
COVID-19.
total
68
articles
obtained
from
PubMed
studies
reported
that
(i)
disease
was
related
haematuria
and
proteinuria
(ii)
typical
sediment
noticed
COVID-19-associated
AKI
patients.
emphasizes
microscopic
examination
support
clinicians
diagnosing
severity.
Journal of Medical Virology,
Journal Year:
2025,
Volume and Issue:
97(3)
Published: March 1, 2025
ABSTRACT
Coronavirus
disease
2019
(COVID‐19)
global
pandemic
has
affected
more
than
600
million
people
up
to
date.
The
symptomatology
and
severity
of
COVID‐19
are
very
broad,
there
still
concerns
about
the
long‐term
sequelae
that
it
can
have
on
discharged
patients.
development
pulmonary
fibrotic
after
this
infection
is
especially
worrying.
Our
aim
was
determine
if
a
metabolomic
signature
could
predict
sequelae.
It
multicenter
prospective
observation
subcohort
based
COVID‐FIBROTIC
study.
A
analysis
performed
by
nuclear
magnetic
resonance
(NMR)
serum
samples
from
patients
admitted
with
bilateral
pneumonia
collected
2
months
hospital
discharge.
One
year
admission,
clinical,
functional
radiological
data
were
these
same
Finally,
109
(mean
age
57.68
[DS14.03],
65.13%
male)
available.
Fibrotic
1
found
in
33%
them.
Based
NMR
samples,
possible
distinguish
80.82%
sensitivity,
72.22%
specificity
0.83
an
area
under
curve
(AUC)
value
which
would
signs
pattern
sample
collection.
According
metabolites
participating
discriminative
model
univariate
statistics,
glucose,
valine,
fatty
acids
(═CH–CH2–CH═)
suggested
as
potential
biomarkers
COVID‐19.
Trial
Registration
Number
clinicaltrials.gov
NCT04409275
(June
1,
2020).
Metabolomics,
Journal Year:
2025,
Volume and Issue:
21(3)
Published: May 10, 2025
Metabolic
profiling
of
blood
metabolites,
particularly
in
plasma
and
serum,
is
vital
for
studying
human
diseases,
conditions,
drug
interventions
toxicology.
The
clinical
significance
arises
from
its
close
ties
to
all
cells
facile
accessibility.
However,
patient-specific
variables
such
as
age,
sex,
diet,
lifestyle
health
status,
along
with
pre-analytical
conditions
(sample
handling,
storage,
etc.),
can
significantly
affect
metabolomic
measurements
whole
blood,
plasma,
or
serum
studies.
These
factors,
referred
confounders,
must
be
mitigated
reveal
genuine
metabolic
changes
due
illness
intervention
onset.
This
review
aims
aid
metabolomics
researchers
collecting
reliable,
standardized
datasets
NMR-based
(whole/serum/plasma)
metabolomics.
goal
reduce
the
impact
confounding
factors
enhance
inter-laboratory
comparability,
enabling
more
meaningful
outcomes
outlines
main
affecting
metabolite
levels
offers
practical
suggestions
what
measure
expect,
how
mitigate
properly
prepare,
handle
store
biosamples
report
data
targeted
studies
serum.
Metabolites,
Journal Year:
2024,
Volume and Issue:
14(7), P. 380 - 380
Published: July 9, 2024
This
prospective
study
in
Hong
Kong
aimed
at
identifying
prognostic
metabolomic
and
immunologic
biomarkers
for
Coronavirus
Disease
2019
(COVID-19).
We
examined
327
patients,
mean
age
55
(19-89)
years,
whom
33.6%
were
infected
with
Omicron
66.4%
earlier
variants.
The
effect
size
of
disease
severity
on
metabolome
outweighed
others
including
age,
gender,
peak
C-reactive
protein
(CRP),
vitamin
D
viral
levels.
Sixty-five
metabolites
demonstrated
strong
associations
the
majority
(54,
83.1%)
downregulated
severe
(z
score:
-3.30
to
-8.61).
Ten
cytokines/chemokines
(
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(18), P. 14371 - 14371
Published: Sept. 21, 2023
The
global
COVID-19
pandemic
resulted
in
widespread
harms
but
also
rapid
advances
vaccine
development,
diagnostic
testing,
and
treatment.
As
the
disease
moves
to
endemic
status,
need
identify
characteristic
biomarkers
of
for
diagnostics
or
therapeutics
has
lessened,
lessons
can
still
be
learned
inform
biomarker
research
dealing
with
future
pathogens.
In
this
work,
we
test
five
sets
research-derived
against
an
independent
targeted
quantitative
Liquid
Chromatography–Mass
Spectrometry
metabolomics
dataset
evaluate
how
robustly
these
proposed
panels
would
distinguish
between
COVID-19-positive
negative
patients
a
hospital
setting.
We
further
crowdsourced
panel
comprising
most
commonly
mentioned
literature
2020
2023.
best-performing
dataset—measured
by
F1
score
(0.76)
AUROC
(0.77)—included
nine
biomarkers:
lactic
acid,
glutamate,
aspartate,
phenylalanine,
β-alanine,
ornithine,
arachidonic
choline,
hypoxanthine.
Panels
fewer
metabolites
performed
less
well,
showing
weaker
statistical
significance
cohort
than
originally
reported
their
respective
discovery
studies.
Whilst
studies
reviewed
here
were
small
may
subject
confounders,
it
is
desirable
that
resilient
across
cohorts
if
they
are
find
use
clinic,
highlighting
importance
assessing
robustness
reproducibility
analyses
populations.
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Sept. 13, 2023
The
mechanisms
driving
SARS-CoV-2
susceptibility
remain
poorly
understood,
especially
the
factors
determining
why
unvaccinated
individuals
uninfected
despite
high-risk
exposures.
To
understand
lipid
and
metabolite
profiles
related
with
COVID-19
disease
progression.
We
collected
samples
from
an
exceptional
group
of
healthcare
workers
heavily
exposed
to
but
not
infected
('non-susceptible')
subjects
who
became
during
follow-up
('susceptible'),
including
non-hospitalized
hospitalized
patients
different
severity
providing
at
early
stages.
Then,
we
analyzed
their
plasma
metabolomic
using
mass
spectrometry
coupled
liquid
gas
chromatography.
show
specific
lipids
metabolites
that
could
explain
severity.
More
importantly,
non-susceptible
a
unique
lipidomic
pattern
characterized
by
upregulation
most
lipids,
ceramides
sphingomyelin,
which
be
interpreted
as
markers
low
infection.
This
study
strengthens
findings
other
researchers
about
importance
studying
relevant
pathogenesis.
Clinical Chemistry and Laboratory Medicine (CCLM),
Journal Year:
2023,
Volume and Issue:
62(4), P. 770 - 788
Published: Nov. 13, 2023
The
stratification
of
individuals
suffering
from
acute
and
post-acute
SARS-CoV-2
infection
remains
a
critical
challenge.
Notably,
biomarkers
able
to
specifically
monitor
viral
progression,
providing
details
about
patient
clinical
status,
are
still
not
available.
Herein,
quantitative
metabolomics
is
progressively
recognized
as
useful
tool
describe
the
consequences
virus-host
interactions
considering
also
metadata.
Diseases,
Journal Year:
2024,
Volume and Issue:
12(3), P. 43 - 43
Published: Feb. 23, 2024
The
immune
response
to
infectious
diseases
is
directly
influenced
by
metabolic
activities.
COVID-19
a
disease
that
affects
the
entire
body
and
can
significantly
impact
cellular
metabolism.
Recent
studies
have
focused
their
analysis
on
potential
connections
between
post-infection
stages
of
SARS-CoV2
different
pathways.
spike
S1
antigen
was
found
in
vitro
IgG
antibody
memory
for
PBMCs
when
obtaining
PBMC
cultures
60–90
days
post
infection,
significant
increase
S-adenosyl
homocysteine,
sarcosine,
arginine
detected
mass
spectrometric
analysis.
involvement
these
metabolites
physiological
recovery
from
viral
infections
activity
well
documented,
they
may
provide
new
simple
method
better
comprehend
leukocytes.
Moreover,
there
change
metabolism
tryptophan
urea
cycle
pathways
leukocytes
with
memory.
With
data,
together
results
literature,
it
seems
leukocyte
reprogrammed
after
pathogenesis
activating
certain
amino
acid
pathways,
which
be
related
protective
immunity
against
SARS-CoV2.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(22), P. 12199 - 12199
Published: Nov. 13, 2024
The
COVID-19
outbreak
caused
saturations
of
hospitals,
highlighting
the
importance
early
patient
triage
to
optimize
resource
prioritization.
Herein,
our
objective
was
test
if
high
definition
metabolomics,
combined
with
ML,
can
improve
prognostication
and
performance
over
standard
clinical
parameters
using
COVID
infection
as
an
example.
Using
resolution
mass
spectrometry,
we
obtained
metabolomics
profiles
patients
them
design
machine
learning
(ML)
algorithms
predicting
severity
(herein
determined
need
for
mechanical
ventilation
during
care).
A
total
64
PCR-positive
at
Poitiers
CHU
were
recruited.
Clinical
investigations
conducted
8
days
after
onset
symptoms.
We
show
that
could
predict
good
(AUC
ROC
curve:
0.85),
SpO2,
first
respiratory
rate,
Horowitz
quotient
age
most
important
variables.
However,
prediction
substantially
improved
by
use
=
0.92).
Our
small-scale
study
demonstrates
diagnosis
prognosis
algorithms,
thus
be
a
key
player
in
future
discovery
new
biological
signals.
This
technique
is
easily
deployable
clinic,
learning,
it
help
mathematical
models
needed
advance
towards
personalized
medicine.